Orthofix Medical Inc.

NASDAQ: OFIX · Real-Time Price · USD
14.25
0.23 (1.64%)
At close: Aug 15, 2025, 2:42 PM

Orthofix Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
203.12M 193.65M 215.66M 196.61M 198.62M 188.61M 200.41M 184.01M 187.02M 175.2M 122.23M 114M 118.07M 106.42M 125.06M 112.43M 121.39M 105.59M
Cost of Revenue
63.59M 72.03M 58.27M 61.55M 68.19M 65.59M 68.06M 64.24M 67.47M 64.88M 33.05M 30.57M 31.6M 28.32M 33.25M 28.31M 27.44M 25.91M
Gross Profit
139.53M 121.62M 157.38M 135.05M 130.43M 123.02M 132.36M 119.76M 119.55M 110.33M 89.18M 83.42M 86.47M 78.1M 91.81M 84.12M 93.95M 79.68M
Operating Income
-16M -48.87M -11.48M -18.9M -21.74M -28.17M -18.87M -24.45M -36.63M -55.58M -8.77M -5.37M -7.26M -8.58M -9.35M -313K 4.27M -2.92M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-14.22M -52.13M -29.71M -26.64M -32.36M -35.17M -22.05M -28.39M -37.92M -60.33M -6.99M -9.37M 3.04M -4.39M -9.61M -2.54M 4.67M -6.02M
Net Income
-14.08M -53.09M -29.15M -27.39M -33.44M -36.02M -22.17M -28.86M -39.43M -60.94M -7.06M -10.72M 2.49M -4.46M -32.81M -2.17M 2.42M -5.82M
Selling & General & Admin
136.49M 132.98M 136.48M 130.14M 134.12M 131.69M 132.28M 122.08M 133.43M 142.6M 84.79M 74.78M 75.73M 73.47M 75.36M 72.41M 75.67M 67.23M
Research & Development
15.93M 19.77M 18.81M 17.29M 18.05M 19.49M 18.94M 18.56M 19.42M 23.31M 13.15M 11.94M 12.76M 11.21M 13.24M 12.36M 13.12M 10.9M
Other Expenses
3.11M 17.75M 8.08M 6.52M n/a -1.27M 766K n/a -20K 676K n/a 2.07M 2.05M 2M 185K -1.79M 951K -2.69M
Operating Expenses
155.54M 170.49M 163.37M 153.95M 152.17M 151.18M 151.22M 140.64M 157.48M 165.91M 97.95M 88.8M 90.54M 86.68M 88.6M 86.73M 90.76M 80.09M
Interest Expense
3.95M 4.51M 14.92M 5.21M 4.94M 4.56M 4.5M 1.58M 1.27M 1.29M 229K 277K 407K 375K 437K 433K 550K 417K
Selling & Marketing Expenses
n/a n/a -296.84M 96.58M 100.22M 100.04M 97.75M 94.95M 99.25M 93.79M 59.32M 55.46M 59.89M 54.14M 57.1M 56.1M 57.34M 50.78M
Cost & Expenses
219.12M 242.52M 227.13M 215.5M 220.36M 216.78M 219.28M 204.88M 224.95M 230.78M 131M 119.37M 122.14M 115M 121.86M 115.04M 118.2M 106.01M
Income Tax Expense
-142K 961K -564K 751K 1.08M 851K 125K 472K 1.51M 611K 75K 1.34M 553K 71K 23.21M -364K 2.25M -207K
Shares Outstanding (Basic)
39.5M 39.19M 38.7M 38.49M 38.02M 37.74M 37.3M 37.25M 36.76M 35.73M 20.2M 20.09M 20.03M 19.9M 19.81M 19.77M 19.65M 19.39M
Shares Outstanding (Diluted)
39.5M 39.19M 38.7M 38.49M 38.02M 37.74M 37.3M 37.25M 36.76M 35.73M 20.2M 20.09M 20.11M 19.9M 19.86M 19.77M 19.94M 19.53M
EPS (Basic)
-0.36 -1.35 -0.75 -0.71 -0.88 -0.95 -0.59 -0.77 -1.07 -1.71 -0.35 -0.53 0.12 -0.22 -1.66 -0.11 0.12 -0.3
EPS (Diluted)
-0.36 -1.35 -0.75 -0.71 -0.88 -0.95 -0.59 -0.77 -1.07 -1.71 -0.35 -0.53 0.12 -0.22 -1.65 -0.11 0.12 -0.3
EBITDA
7.72M -11.95M 12.54M -4.64M -13.38M -15.75M -3.58M -13.71M -23.32M -46.37M -4.48M -1.52M 9.96M 3.5M -1.72M 5.05M 12.78M 1.84M
EBIT
-10.27M -47.63M -14.79M -21.43M -27.42M -30.61M -17.55M -26.81M -36.65M -59.04M -6.76M -9.1M 3.45M -4.01M -9.17M -2.1M 5.22M -5.61M
Depreciation & Amortization
18M 35.68M 27.33M 16.79M 14.03M 14.86M 13.97M 13.1M 13.33M 12.67M 7.42M 7.57M 6.51M 7.52M 7.45M 7.15M 7.56M 7.44M